Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Pulmonary mucus: Pediatric perspective.

Rogers DF.

Pediatr Pulmonol. 2003 Sep;36(3):178-88. Review.

PMID:
12910578
2.

Airway hypersecretion in allergic rhinitis and asthma: new pharmacotherapy.

Rogers DF.

Curr Allergy Asthma Rep. 2003 May;3(3):238-48. Review.

PMID:
12662474
3.

Treatment of airway mucus hypersecretion.

Rogers DF, Barnes PJ.

Ann Med. 2006;38(2):116-25. Review.

PMID:
16581697
4.

Airway mucus hypersecretion in asthma: an undervalued pathology?

Rogers DF.

Curr Opin Pharmacol. 2004 Jun;4(3):241-50. Review.

PMID:
15140415
5.

Mucus pathophysiology in COPD: differences to asthma, and pharmacotherapy.

Rogers DF.

Monaldi Arch Chest Dis. 2000 Aug;55(4):324-32. Review.

PMID:
11057087
6.

Current and future therapies for airway mucus hypersecretion.

Barnes PJ.

Novartis Found Symp. 2002;248:237-49; discussion 249-53, 277-82. Review.

PMID:
12568498
7.

Mucus and MUC in asthma.

Morcillo EJ, Cortijo J.

Curr Opin Pulm Med. 2006 Jan;12(1):1-6. Review.

PMID:
16357571
8.

Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy.

Lai HY, Rogers DF.

Curr Opin Allergy Clin Immunol. 2010 Feb;10(1):67-76. doi: 10.1097/ACI.0b013e328334643a. Review.

PMID:
19907312
9.
10.

Mucoactive agents for airway mucus hypersecretory diseases.

Rogers DF.

Respir Care. 2007 Sep;52(9):1176-93; discussion 1193-7. Review.

11.

Mucin-producing elements and inflammatory cells.

Jeffery P, Zhu J.

Novartis Found Symp. 2002;248:51-68; discussion 68-75, 277-82. Review.

PMID:
12568488
12.

New pharmacotherapy for airway mucus hypersecretion in asthma and COPD: targeting intracellular signaling pathways.

Lai H, Rogers DF.

J Aerosol Med Pulm Drug Deliv. 2010 Aug;23(4):219-31. doi: 10.1089/jamp.2009.0802. Review.

PMID:
20695774
13.

Neural control of airway mucus secretion.

Rogers DF, Dewar A.

Biomed Pharmacother. 1990;44(9):447-53. Review.

PMID:
2081272
14.

The airway goblet cell.

Rogers DF.

Int J Biochem Cell Biol. 2003 Jan;35(1):1-6. Review.

PMID:
12467641
15.

Role of neutrophils in mucus hypersecretion in COPD and implications for therapy.

Kim S, Nadel JA.

Treat Respir Med. 2004;3(3):147-59. Review.

PMID:
15219174
16.

Physiology of airway mucus secretion and pathophysiology of hypersecretion.

Rogers DF.

Respir Care. 2007 Sep;52(9):1134-46; discussion 1146-9. Review.

17.

Effects of concentrated ambient particles on normal and hypersecretory airways in rats.

Harkema JR, Keeler G, Wagner J, Morishita M, Timm E, Hotchkiss J, Marsik F, Dvonch T, Kaminski N, Barr E.

Res Rep Health Eff Inst. 2004 Aug;(120):1-68; discussion 69-79.

PMID:
15543855
18.

Mucoactive drugs for asthma and COPD: any place in therapy?

Rogers DF.

Expert Opin Investig Drugs. 2002 Jan;11(1):15-35. Review.

PMID:
11772318
19.

Tyrosine kinase inhibitors: a new approach for asthma.

Wong WS, Leong KP.

Biochim Biophys Acta. 2004 Mar 11;1697(1-2):53-69. Review.

PMID:
15023350
20.

Therapy for chronic obstructive pulmonary disease in the 21st century.

Donnelly LE, Rogers DF.

Drugs. 2003;63(19):1973-98. Review.

PMID:
12962514
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk